Metabolomic study of carotid-femoral pulse-wave velocity in women

Journal of Hypertension

Volumn 33, Issue 4, 2015, Pages 791-796

  Menni, Cristina ^a   Mangino, Massimo ^a   Cecelja, Marina ^b   Psatha, Maria ^a   Brosnan, Mary J ^c   Trimmer, Jeff ^d   Mohney, Robert P ^e   Chowienczyk, Phil ^b   Padmanabhan, Sandosh ^f   Spector, Tim D ^a   Valdes, Ana M ^a,g  

^a Department of Twin Research and Genetic Epidemiology ^*  (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c PFIZER INC   (United States)

^d BioElectron Technology Corporation   (United States)

^e Metabalon Inc   (United States)

^f UNIVERSITY OF GLASGOW   (United Kingdom)

^g NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Biomarkers; Metabolomics; Pulse wave velocity

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLYCERIC ACID; GLYCINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCINNAMIC ACID; HYDROXYPROLINE; INDOLEPROPIONATE; METHIONINE; MOLECULAR MARKER; PHENYLACETYLGLUTAMINE; PURINERGIC RECEPTOR; SERINE; THREONATE; UNCLASSIFIED DRUG; UREA; URIDINE; AMINO ACID; BIOLOGICAL MARKER;

ADULT; AGED; ARTERIAL STIFFNESS; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS; CARDIOVASCULAR RISK; CAROTID PULSE WAVE VELOCITY; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; FEMORAL PULSE WAVE VELOCITY; FRAMINGHAM RISK SCORE; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; METABOLOMICS; MONOZYGOTIC TWINS; PRIORITY JOURNAL; PULSE WAVE; RISK FACTOR; ADOLESCENT; ARTERY; BLOOD; METABOLISM; MIDDLE AGED; TWINS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINO ACIDS; ARTERIES; BIOMARKERS; BLOOD PRESSURE; FEMALE; HUMANS; METABOLOMICS; MIDDLE AGED; PULSE WAVE ANALYSIS; RISK FACTORS; VASCULAR STIFFNESS; YOUNG ADULT;

EID: 84938948388     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000467     Document Type: Conference Paper

References (33)

1. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010; 55:1318-1327.
2. Willum-Hansen T, Staessen JA, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen H, et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 2006; 113:664-670.
3. Payne RA, Wilkinson IB, Webb DJ. Arterial stiffness and hypertension: emerging concepts. Hypertension 2010; 55:9-14.
4. Marti CN, Gheorghiade M, Kalogeropoulos AP, Georgiopoulou VV, Quyyumi AA, Butler J. Endothelial dysfunction, arterial stiffness, and heart failure. J Am Coll Cardiol 2012; 60:1455-1469.
5. Cecelja M, Jiang B, McNeill K, Kato B, Ritter J, Spector T, et al. Increased wave reflection rather than central arterial stiffness is the main determinant of raised pulse pressure in women and relates to mismatch in arterial dimensions: a twin study. J Am Coll Cardiol 2009; 54:695-703.
6. McEniery CM, Yasmin. Hall IR, Qasem A, Wilkinson IB, Cockcroft JR. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol 2005; 46:1753-1760.
7. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27:2588-2605.
8. Giannattasio C, Failla M, Capra A, Scanziani E, Amigoni M, Boffi L, et al. Increased arterial stiffness in normoglycemic normotensive offspring of type 2 diabetic parents. Hypertension 2008; 51:182-187.
9. Riggio S, Mandraffino G, Sardo MA, Iudicello R, Camarda N, Imbalzano E, et al. Pulse wave velocity and augmentation index, but not intimamedia thickness, are early indicators of vascular damage in hypercholesterolemic children. Eur J Clin Invest 2010; 40:250-257.
10. Giannattasio C, Mangoni AA, Failla M, Carugo S, Stella ML, Stefanoni P, et al. Impaired radial artery compliance in normotensive subjects with familial hypercholesterolemia. Atherosclerosis 1996; 124:249-260.
11. Karras A, Haymann JP, Bozec E, Metzger M, Jacquot C, Maruani G, et al. Large artery stiffening and remodeling are independently associated with all-cause mortality and cardiovascular events in chronic kidney disease. Hypertension 2012; 60:1451-1457.
12. Hollywood K, Brison DR, Goodacre R. Metabolomics: current technologies and future trends. Proteomics 2006; 6:4716-4723.
13. Anderson SG, Sanders TA, Cruickshank JK. Plasma fatty acid composition as a predictor of arterial stiffness and mortality. Hypertension 2009; 53:839-845.
14. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008; 117:743-753.
15. Moayyeri A, Hammond CJ, Valdes AM, Spector TD. Cohort profile: TwinsUK and Healthy Ageing Twin Study. Int J Epidemiol 2013; 42:76-85; doi: 10.1093/ije/dyr207.
16. Menni C, Kastenmuller G, Petersen AK, Bell JT, Psatha M, Tsai PC, et al. Metabolomic markers reveal novel pathways of ageing and early development in human populations. Int J Epidemiol 2013; 42:1111-1119.
17. Grundberg E, Small KS, Hedman AK, Nica AC, Buil A, Keildson S, et al. Mapping cis-and trans-regulatory effects across multiple tissues in twins. Nat Genet 2012; 44:1084-1089.
18. Menni C, Zhai G, Macgregor A, Prehn C, Romisch-Margl W, Suhre K, et al. Targeted metabolomics profiles are strongly correlated with nutritional patterns in women. Metabolomics 2013; 9:506-514.
19. Lunder M, Janic M, Kejzar N, Sabovic M. Associations among different functional and structural arterial wall properties and their relations to traditional cardiovascular risk factors in healthy subjects: a cross-sectional study. BMC Cardiovasc Disord 2012; 12:29.
20. Da Silva CG, Specht A, Wegiel B, Ferran C, Kaczmarek E. Mechanism of purinergic activation of endothelial nitric oxide synthase in endothelial cells. Circulation 2009; 119:871-879.
21. Krylova IB, Bulion VV, Selina EN, Mironova GD, Sapronov NS. Effect of uridine on energy metabolism, LPO, and antioxidant system in the myocardium under conditions of acute coronary insufficiency. Bull Exp Biol Med 2012; 153:644-646.
22. McEniery CM, Wallace S, Mackenzie IS, McDonnell B, Yasmin. Newby DE, et al. Endothelial function is associated with pulse pressure, pulse wave velocity, and augmentation index in healthy humans. Hypertension 2006; 48:602-608.
23. Levy E, Jaskolski M, Grubb A. The role of cystatin C in cerebral amyloid angiopathy and stroke: cell biology and animal models. Brain Pathol 2006; 16:60-70.
24. Zimmerman L, Egestad B, Jornvall H, Bergstrom J. Identification and determination of phenylacetylglutamine, a major nitrogenous metabolite in plasma of uremic patients. Clin Nephrol 1989; 32:124-128.
25. Holmes E, Loo RL, Stamler J, Bictash M, Yap IK, Chan Q, et al. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 2008; 453:396-400.
26. Ito M, Nagasawa M, Omae N, Ide T, Akasaka Y, Murakami K. Differential regulation of CIDEA and CIDEC expression by insulin via Akt1/2-and JNK2-dependent pathways in human adipocytes. J Lipid Res 2011; 52:1450-1460.
27. Rubio-Cabezas O, Puri V, Murano I, Saudek V, Semple RK, Dash S, et al. Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC. EMBO Mol Med 2009; 1:280-287.
28. Yonezawa T, Kurata R, Kimura M, Inoko H. Which CIDE are you on? Apoptosis and energy metabolism. Mol Biosyst 2011; 7:91-100.
29. Hall AM, Brunt EM, Klein S, Finck BN. Hepatic expression of cell deathinducing DFFA-like effector C in obese subjects is reduced by marked weight loss. Obesity (Silver Spring) 2010; 18:417-419.
30. Erlinge D, Harnek J, van Heusden C, Olivecrona G, Jern S, Lazarowski E. Uridine triphosphate (UTP) is released during cardiac ischemia. Int J Cardiol 2005; 100:427-433.
31. Ben-Shlomo Y, Spears M, Boustred C, May M, Anderson SG, Benjamin EJ, et al. Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects. J Am Coll Cardiol 2014; 63:636-646.
32. Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM, et al. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation 2010; 121:505-511.
33. Kones R. Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey. Drug Des Dev Ther 2011; 5:325-380.